img

Global Crysvita Injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Crysvita Injection Market Research Report 2024

X-linked hypophosphatemia, or XLH, is a hereditary skeletal disease triggered by excess production of the hormone fibroblast growth factor 23. FGF23 causes phosphate urinary excretion and hinders patients' ability to produce vitamin D. CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older.
According to Mr Accuracy reports’s new survey, global Crysvita Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Crysvita Injection market research.
Key manufacturers engaged in the Crysvita Injection industry include Kyowa Kirin and Ultragenyx Pharmaceutical etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Crysvita Injection were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Crysvita Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Crysvita Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Kyowa Kirin
Ultragenyx Pharmaceutical
Segment by Type
10 mg/mL
20 mg/mL
30 mg/mL

Segment by Application


Children
Adults

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Crysvita Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Crysvita Injection Market Overview
1.1 Product Overview and Scope of Crysvita Injection
1.2 Crysvita Injection Segment by Type
1.2.1 Global Crysvita Injection Market Value Comparison by Type (2024-2034)
1.2.2 10 mg/mL
1.2.3 20 mg/mL
1.2.4 30 mg/mL
1.3 Crysvita Injection Segment by Application
1.3.1 Global Crysvita Injection Market Value by Application: (2024-2034)
1.3.2 Children
1.3.3 Adults
1.4 Global Crysvita Injection Market Size Estimates and Forecasts
1.4.1 Global Crysvita Injection Revenue 2018-2034
1.4.2 Global Crysvita Injection Sales 2018-2034
1.4.3 Global Crysvita Injection Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Crysvita Injection Market Competition by Manufacturers
2.1 Global Crysvita Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Crysvita Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Crysvita Injection Average Price by Manufacturers (2018-2023)
2.4 Global Crysvita Injection Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Crysvita Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Crysvita Injection, Product Type & Application
2.7 Crysvita Injection Market Competitive Situation and Trends
2.7.1 Crysvita Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Crysvita Injection Players Market Share by Revenue
2.7.3 Global Crysvita Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Crysvita Injection Retrospective Market Scenario by Region
3.1 Global Crysvita Injection Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Crysvita Injection Global Crysvita Injection Sales by Region: 2018-2034
3.2.1 Global Crysvita Injection Sales by Region: 2018-2023
3.2.2 Global Crysvita Injection Sales by Region: 2024-2034
3.3 Global Crysvita Injection Global Crysvita Injection Revenue by Region: 2018-2034
3.3.1 Global Crysvita Injection Revenue by Region: 2018-2023
3.3.2 Global Crysvita Injection Revenue by Region: 2024-2034
3.4 North America Crysvita Injection Market Facts & Figures by Country
3.4.1 North America Crysvita Injection Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Crysvita Injection Sales by Country (2018-2034)
3.4.3 North America Crysvita Injection Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Crysvita Injection Market Facts & Figures by Country
3.5.1 Europe Crysvita Injection Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Crysvita Injection Sales by Country (2018-2034)
3.5.3 Europe Crysvita Injection Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crysvita Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Crysvita Injection Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Crysvita Injection Sales by Country (2018-2034)
3.6.3 Asia Pacific Crysvita Injection Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Crysvita Injection Market Facts & Figures by Country
3.7.1 Latin America Crysvita Injection Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Crysvita Injection Sales by Country (2018-2034)
3.7.3 Latin America Crysvita Injection Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Crysvita Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Crysvita Injection Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Crysvita Injection Sales by Country (2018-2034)
3.8.3 Middle East and Africa Crysvita Injection Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crysvita Injection Sales by Type (2018-2034)
4.1.1 Global Crysvita Injection Sales by Type (2018-2023)
4.1.2 Global Crysvita Injection Sales by Type (2024-2034)
4.1.3 Global Crysvita Injection Sales Market Share by Type (2018-2034)
4.2 Global Crysvita Injection Revenue by Type (2018-2034)
4.2.1 Global Crysvita Injection Revenue by Type (2018-2023)
4.2.2 Global Crysvita Injection Revenue by Type (2024-2034)
4.2.3 Global Crysvita Injection Revenue Market Share by Type (2018-2034)
4.3 Global Crysvita Injection Price by Type (2018-2034)
5 Segment by Application
5.1 Global Crysvita Injection Sales by Application (2018-2034)
5.1.1 Global Crysvita Injection Sales by Application (2018-2023)
5.1.2 Global Crysvita Injection Sales by Application (2024-2034)
5.1.3 Global Crysvita Injection Sales Market Share by Application (2018-2034)
5.2 Global Crysvita Injection Revenue by Application (2018-2034)
5.2.1 Global Crysvita Injection Revenue by Application (2018-2023)
5.2.2 Global Crysvita Injection Revenue by Application (2024-2034)
5.2.3 Global Crysvita Injection Revenue Market Share by Application (2018-2034)
5.3 Global Crysvita Injection Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Kyowa Kirin
6.1.1 Kyowa Kirin Corporation Information
6.1.2 Kyowa Kirin Description and Business Overview
6.1.3 Kyowa Kirin Crysvita Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Kyowa Kirin Crysvita Injection Product Portfolio
6.1.5 Kyowa Kirin Recent Developments/Updates
6.2 Ultragenyx Pharmaceutical
6.2.1 Ultragenyx Pharmaceutical Corporation Information
6.2.2 Ultragenyx Pharmaceutical Description and Business Overview
6.2.3 Ultragenyx Pharmaceutical Crysvita Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ultragenyx Pharmaceutical Crysvita Injection Product Portfolio
6.2.5 Ultragenyx Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crysvita Injection Industry Chain Analysis
7.2 Crysvita Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crysvita Injection Production Mode & Process
7.4 Crysvita Injection Sales and Marketing
7.4.1 Crysvita Injection Sales Channels
7.4.2 Crysvita Injection Distributors
7.5 Crysvita Injection Customers
8 Crysvita Injection Market Dynamics
8.1 Crysvita Injection Industry Trends
8.2 Crysvita Injection Market Drivers
8.3 Crysvita Injection Market Challenges
8.4 Crysvita Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Crysvita Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Crysvita Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Crysvita Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Crysvita Injection Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Crysvita Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Crysvita Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Crysvita Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Crysvita Injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Crysvita Injection, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Crysvita Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Crysvita Injection, Product Type & Application
Table 12. Global Key Manufacturers of Crysvita Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Crysvita Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crysvita Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Crysvita Injection Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Crysvita Injection Sales by Region (2018-2023) & (K Units)
Table 18. Global Crysvita Injection Sales Market Share by Region (2018-2023)
Table 19. Global Crysvita Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global Crysvita Injection Sales Market Share by Region (2024-2034)
Table 21. Global Crysvita Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Crysvita Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Crysvita Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Crysvita Injection Revenue Market Share by Region (2024-2034)
Table 25. North America Crysvita Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Crysvita Injection Sales by Country (2018-2023) & (K Units)
Table 27. North America Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America Crysvita Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Crysvita Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Crysvita Injection Sales by Country (2018-2023) & (K Units)
Table 32. Europe Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe Crysvita Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Crysvita Injection Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Crysvita Injection Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Crysvita Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Crysvita Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Crysvita Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Crysvita Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Crysvita Injection Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Crysvita Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Crysvita Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Crysvita Injection Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Crysvita Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Crysvita Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Crysvita Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Crysvita Injection Sales (K Units) by Type (2018-2023)
Table 51. Global Crysvita Injection Sales (K Units) by Type (2024-2034)
Table 52. Global Crysvita Injection Sales Market Share by Type (2018-2023)
Table 53. Global Crysvita Injection Sales Market Share by Type (2024-2034)
Table 54. Global Crysvita Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Crysvita Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Crysvita Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Crysvita Injection Revenue Market Share by Type (2024-2034)
Table 58. Global Crysvita Injection Price (US$/Unit) by Type (2018-2023)
Table 59. Global Crysvita Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global Crysvita Injection Sales (K Units) by Application (2018-2023)
Table 61. Global Crysvita Injection Sales (K Units) by Application (2024-2034)
Table 62. Global Crysvita Injection Sales Market Share by Application (2018-2023)
Table 63. Global Crysvita Injection Sales Market Share by Application (2024-2034)
Table 64. Global Crysvita Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Crysvita Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Crysvita Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Crysvita Injection Revenue Market Share by Application (2024-2034)
Table 68. Global Crysvita Injection Price (US$/Unit) by Application (2018-2023)
Table 69. Global Crysvita Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Kyowa Kirin Corporation Information
Table 71. Kyowa Kirin Description and Business Overview
Table 72. Kyowa Kirin Crysvita Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Kyowa Kirin Crysvita Injection Product
Table 74. Kyowa Kirin Recent Developments/Updates
Table 75. Ultragenyx Pharmaceutical Corporation Information
Table 76. Ultragenyx Pharmaceutical Description and Business Overview
Table 77. Ultragenyx Pharmaceutical Crysvita Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Ultragenyx Pharmaceutical Crysvita Injection Product
Table 79. Ultragenyx Pharmaceutical Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Crysvita Injection Distributors List
Table 83. Crysvita Injection Customers List
Table 84. Crysvita Injection Market Trends
Table 85. Crysvita Injection Market Drivers
Table 86. Crysvita Injection Market Challenges
Table 87. Crysvita Injection Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Crysvita Injection
Figure 2. Global Crysvita Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Crysvita Injection Market Share by Type in 2024 & 2034
Figure 4. 10 mg/mL Product Picture
Figure 5. 20 mg/mL Product Picture
Figure 6. 30 mg/mL Product Picture
Figure 7. Global Crysvita Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Crysvita Injection Market Share by Application in 2024 & 2034
Figure 9. Children
Figure 10. Adults
Figure 11. Global Crysvita Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Crysvita Injection Market Size (2018-2034) & (US$ Million)
Figure 13. Global Crysvita Injection Sales (2018-2034) & (K Units)
Figure 14. Global Crysvita Injection Average Price (US$/Unit) & (2018-2034)
Figure 15. Crysvita Injection Report Years Considered
Figure 16. Crysvita Injection Sales Share by Manufacturers in 2024
Figure 17. Global Crysvita Injection Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Crysvita Injection Players: Market Share by Revenue in 2024
Figure 19. Crysvita Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Crysvita Injection Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Crysvita Injection Sales Market Share by Country (2018-2034)
Figure 22. North America Crysvita Injection Revenue Market Share by Country (2018-2034)
Figure 23. United States Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Crysvita Injection Sales Market Share by Country (2018-2034)
Figure 26. Europe Crysvita Injection Revenue Market Share by Country (2018-2034)
Figure 27. Germany Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Crysvita Injection Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Crysvita Injection Revenue Market Share by Region (2018-2034)
Figure 34. China Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Crysvita Injection Sales Market Share by Country (2018-2034)
Figure 44. Latin America Crysvita Injection Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Crysvita Injection Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Crysvita Injection Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Crysvita Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Crysvita Injection by Type (2018-2034)
Figure 54. Global Revenue Market Share of Crysvita Injection by Type (2018-2034)
Figure 55. Global Crysvita Injection Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Crysvita Injection by Application (2018-2034)
Figure 57. Global Revenue Market Share of Crysvita Injection by Application (2018-2034)
Figure 58. Global Crysvita Injection Price (US$/Unit) by Application (2018-2034)
Figure 59. Crysvita Injection Value Chain
Figure 60. Crysvita Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed